Dimensional Fund Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$382M Buy
1,949,535
+17,987
+0.9% +$3.49M 0.08% 247
2025
Q4
$335M Buy
1,931,548
+24,038
+1% +$4.38M 0.07% 288
2025
Q3
$364M Buy
1,907,510
+6,155
+0.3% +$1.09M 0.08% 249
2025
Q2
$342M Sell
1,901,355
-11,205
-0.6% -$1.95M 0.08% 241
2025
Q1
$324M Sell
1,912,560
-128,905
-6% -$21.2M 0.08% 236
2024
Q4
$308M Sell
2,041,465
-5,156
-0.3% -$802K 0.07% 266
2024
Q3
$318M Sell
2,046,621
-62,894
-3% -$9.39M 0.08% 251
2024
Q2
$289M Buy
2,109,515
+129,395
+7% +$17.7M 0.08% 258
2024
Q1
$264M Buy
1,980,120
+7,001
+0.4% +$908K 0.07% 284
2023
Q4
$272M Buy
1,973,119
+253
+0% +$33.3K 0.08% 240
2023
Q3
$240M Sell
1,972,866
-17,807
-0.9% -$2.37M 0.08% 245
2023
Q2
$280M Sell
1,990,673
-30,178
-1% -$4.16M 0.09% 211
2023
Q1
$286M Sell
2,020,851
-15,416
-0.8% -$2.21M 0.1% 181
2022
Q4
$319K Sell
2,036,267
-91,304
-4% -$13.1M 0.09% 157
2022
Q3
$261M Sell
2,127,571
-26,880
-1% -$3.54M 0.1% 184
2022
Q2
$287M Sell
2,154,451
-35,687
-2% -$4.86M 0.1% 172
2022
Q1
$300M Buy
2,190,138
+3,219
+0.1% +$449K 0.09% 198
2021
Q4
$378M Buy
2,186,919
+29,895
+1% +$4.55M 0.11% 136
2021
Q3
$313M Sell
2,157,024
-1,101
-0.1% -$161K 0.1% 171
2021
Q2
$285M Buy
2,158,125
+166,433
+8% +$21.8M 0.09% 198
2021
Q1
$256M Buy
1,991,692
+64,214
+3% +$7.91M 0.08% 233
2020
Q4
$230M Buy
1,927,478
+79,856
+4% +$9.74M 0.08% 218
2020
Q3
$212M Sell
1,847,622
-15,127
-0.8% -$1.79M 0.09% 184
2020
Q2
$212M Sell
1,862,749
-51,793
-3% -$5.49M 0.09% 164
2020
Q1
$154M Sell
1,914,542
-27,004
-1% -$2.8M 0.08% 206
2019
Q4
$207M Sell
1,941,546
-21,647
-1% -$2.26M 0.08% 238
2019
Q3
$210M Sell
1,963,193
-17,323
-0.9% -$1.78M 0.08% 213
2019
Q2
$202M Sell
1,980,516
-24,593
-1% -$2.36M 0.08% 219
2019
Q1
$180M Buy
2,005,109
+22,748
+1% +$1.97M 0.07% 249
2018
Q4
$165M Buy
1,982,361
+9,047
+0.5% +$848K 0.07% 242
2018
Q3
$213M Sell
1,973,314
-20,968
-1% -$2.3M 0.08% 216
2018
Q2
$219M Sell
1,994,282
-17,086
-0.8% -$1.78M 0.09% 191
2018
Q1
$202M Sell
2,011,368
-6,805
-0.3% -$697K 0.08% 213
2017
Q4
$199M Sell
2,018,173
-11,451
-0.6% -$1.09M 0.08% 232
2017
Q3
$190M Buy
2,029,624
+4,516
+0.2% +$479K 0.08% 223
2017
Q2
$225M Buy
2,025,108
+3,001
+0.1% +$317K 0.1% 159
2017
Q1
$199M Buy
2,022,107
+99,153
+5% +$9.45M 0.09% 188
2016
Q4
$177M Buy
1,922,954
+39,748
+2% +$3.43M 0.09% 212
2016
Q3
$159M Buy
1,883,206
+143,070
+8% +$12M 0.09% 215
2016
Q2
$142M Buy
1,740,136
+230,885
+15% +$17.6M 0.08% 236
2016
Q1
$108M Buy
1,509,251
+63,133
+4% +$4.23M 0.06% 346
2015
Q4
$103M Buy
1,446,118
+49,332
+4% +$3.32M 0.06% 344
2015
Q3
$85.9M Buy
1,396,786
+203,375
+17% +$14.2M 0.06% 404
2015
Q2
$86.5M Buy
1,193,411
+284,263
+31% +$21M 0.05% 449
2015
Q1
$69.9M Buy
909,148
+62,217
+7% +$4.46M 0.04% 553
2014
Q4
$56.8M Buy
846,931
+284,239
+51% +$17.9M 0.04% 655
2014
Q3
$34.2M Buy
562,692
+9,344
+2% +$576K 0.02% 1027
2014
Q2
$32.5M Buy
553,348
+115,113
+26% +$6.74M 0.02% 1119
2014
Q1
$25.4M Buy
438,235
+40,386
+10% +$2.16M 0.02% 1320
2013
Q4
$21.3M Sell
397,849
-1,916
-0.5% -$114K 0.02% 1483
2013
Q3
$24.7M Buy
399,765
+43,042
+12% +$2.58M 0.02% 1167
2013
Q2
$21.6M Buy
+356,723
New +$21.3M 0.02% 1192

Other funds holding DGX

Dimensional Fund Advisors's DGX Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Quest Diagnostics (DGX) stake by 0.93% in Q1 2026, buying an estimated $3.49M and bringing the position to 1,949,535 shares worth $382M. The position accounts for 0.08% of the portfolio, ranked #247.

Dimensional Fund Advisors first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Dimensional Fund Advisors held 1,949,535 shares of Quest Diagnostics worth $382M as of Q1 2026.
  • Dimensional Fund Advisors bought 17,987 Quest Diagnostics shares in Q1 2026, an estimated $3.49M.
  • Quest Diagnostics made up 0.08% of Dimensional Fund Advisors's portfolio in Q1 2026, its #247 holding.
  • Dimensional Fund Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.